118 related articles for article (PubMed ID: 11243422)
1. Restoration of normal ventricular electrophysiology in renovascular hypertensive rabbits after treatment with losartan.
Rials SJ; Xu X; Wu Y; Liu T; Marinchack RA; Kowey PR
J Cardiovasc Pharmacol; 2001 Mar; 37(3):317-23. PubMed ID: 11243422
[TBL] [Abstract][Full Text] [Related]
2. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation.
Rials SJ; Wu Y; Xu X; Filart RA; Marinchak RA; Kowey PR
Circulation; 1997 Aug; 96(4):1330-6. PubMed ID: 9286966
[TBL] [Abstract][Full Text] [Related]
3. Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits.
Rials SJ; Xu X; Wu Y; Marinchak RA; Kowey PR
Am J Physiol; 1998 Oct; 275(4):H1216-24. PubMed ID: 9746469
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
5. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
[TBL] [Abstract][Full Text] [Related]
7. Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs.
Brilla CG
Cardiovasc Res; 2000 May; 46(2):324-31. PubMed ID: 10773237
[TBL] [Abstract][Full Text] [Related]
8. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
[TBL] [Abstract][Full Text] [Related]
9. Losartan controlled blood pressure and reduced left ventricular hypertrophy but did not alter arrhythmias in hypertensive men with preserved systolic function.
Zakynthinos E; Pierrutsakos Ch; Daniil Z; Papadogiannis D
Angiology; 2005; 56(4):439-49. PubMed ID: 16079926
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in electrical remodeling and susceptibility to ventricular arrhythmias in rabbits with left ventricular hypertrophy.
Biagetti MO; Quinteiro RA
Heart Rhythm; 2006 Jul; 3(7):832-9. PubMed ID: 16818217
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients.
Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H; Suzuki H
J Cardiovasc Pharmacol; 2004 Mar; 43(3):380-6. PubMed ID: 15076221
[TBL] [Abstract][Full Text] [Related]
12. Regression of left ventricular hypertrophy in experimental renovascular hypertension: diastolic dysfunction depends more on myocardial collagen than it does on myocardial mass.
Dussaillant GR; Gonzalez H; Cespedes C; Jalil JE
J Hypertens; 1996 Sep; 14(9):1117-23. PubMed ID: 8986913
[TBL] [Abstract][Full Text] [Related]
13. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
[TBL] [Abstract][Full Text] [Related]
14. Losartan reduces left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does not affect diastolic cardiac function.
Zakynthinos E; Pierutsakos Ch; Konstantinidis K; Zakynthinos S; Papadogiannis D
Angiology; 2004; 55(6):669-78. PubMed ID: 15547653
[TBL] [Abstract][Full Text] [Related]
15. Restoration of action potential duration and transient outward current by regression of left ventricular hypertrophy.
Yokoshiki H; Kohya T; Tomita F; Tohse N; Nakaya H; Kanno M; Kitabatake A
J Mol Cell Cardiol; 1997 May; 29(5):1331-9. PubMed ID: 9201619
[TBL] [Abstract][Full Text] [Related]
16. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
17. Regression of cardiac hypertrophy and myosin isoenzyme patterns by losartan and captopril in renovascular hypertensive rats.
Ling Q; Guo ZG; Su Z; Guo X
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):206-10. PubMed ID: 7976371
[TBL] [Abstract][Full Text] [Related]
18. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
19. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
Linz W; Gohlke P; Unger T; Schölkens BA
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint study.
Bang CN; Okin PM; Køber L; Wachtell K; Gottlieb AB; Devereux RB
J Hypertens; 2014 Mar; 32(3):667-72. PubMed ID: 24379001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
